1Weber C A,Salazar E P, Stewart S A, et al. ERCC2:cDNA cloning and molecular characterization of a human nudeotide excision repair gene with hgh homology to yeast RAD3. EMBO J, 1990,9(5):1437.
2Sehaeffer L, Moncollin V, Roy R, et al. The ERCC2/DNA repair prote in is associated with the class Ⅱ BTF2/TFIIH transcription factor. EMBO J, 1994,13(4) :2388.
3Shen M R,Jones I M, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy human. Cancer Res, 1998,58(4) :604.
4Friedberg E C. DNA damage and repair. Nature,2003,421 (1) :436.
5Butkiewicz D, Rusin M, Enewold L, et al. Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis,2001,22(3) :593.
6Brobghton B C, Steingrimsdottir H, Lehmann A R. Five polymorphisms in the coding sequence of the xeroderma pigmentosum group D gene. Mutat Res, 1996,362(2) :209.
7Hemroinkik, XU G, Angelini S, et al. XPD exon 10 and 23 polymorphisms and DNA repir in human skin in situ. Carcinogenesis,2001,22(4) :1185.
8Matullo G,Peluso M, Polidoro S,et al. Combination of DNA repair gene Single nucleotide poIymorphisms and increased levels of DNA adducts in a populationbased study. Cancer Epidemiol Biomarkers Prev,2003,12 (2):674.
9Duell E J, Wiencke J K, Cheng T J, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis, 2000, 21 (3) : 965.
10Palli D,Russo A, Masala G, et al. DNA adduct levels and DNA repair polymorphisms in traffic - exposed workers and a general population sample. Int J Cancer, 2001,94(4) : 121.
6Cho H J, Kim S R, Kim H R, et al. Modem Outcome and Risk Analysis of Surgically Resected Occult N2 Non-Small Cell Lung Cancer[J]. Ann Thorac Surg, 2014, 4975(14): 490.
7Rengan R, Ho A, Owen J B, et al. Impact of sociodemo- graphic factors on the radiotherapeutic management of lung cancer: Results of a Quality Research in Radiation Oncology Survey[J]. Pract Radiat Oncol, 2014, 4(3) : e167.
8Liang G, Xing D, Miao X, et al. Sequence variat ions in the DNA repairgene XPD of lung cancer [ J ]. Int J Cancer, 2003, 105(5): 669.
9Leng X F, Chan M W, Xian L, et al. Combined analysis of mRNA expression of ERCC1, BAG-l, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell ltm: cancer who received adjuvant ehemotherapy[J ]. J Exp Clin Cancer Res, 2012, 23(31): 25.
10Tsai M S, Kuo Y H, Chiu Y F, et al. Down-regulation of Rad51 expression overcomes drug resistance to gemcitabine in human non-small-cell lung cancer cells[J]. J Pbarmacol Exp Ther, 2010, 335(3): 830.
